Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Meher Nasri"'
Autor:
Feryel Letaief, Meher Nasri, Mouna Ayadi, Khedija Meddeb, Amina Mokrani, Yosra Yahyaoui, Nesrine Chraiet, Henda Raies, Amel Mezlini
Publikováno v:
Cancer Biology & Medicine, Vol 14, Iss 3, Pp 327-334 (2017)
Objective : To assess the response rate of patients with rectal adenocarcinoma to neoadjuvant therapy and to identify the predictors of histological regression after neoadjuvant radiotherapy (RT) or concurrent chemoradiotherapy (CCRT). Methods : This
Externí odkaz:
https://doaj.org/article/b1a6a80d8e8148e6bbdd3b16b796f422
Publikováno v:
Cancer Biology & Medicine, Vol 14, Iss 2, Pp 187-190 (2017)
A new case of epithelioid hemangioendothelioma is reported to have occurred to a 67-year-old patient who consulted for right-sided chest pain. The work-up showed multiple right pulmonary lesions associated with bilateral moderate pleural effusion and
Externí odkaz:
https://doaj.org/article/06281deb77d14d96877ddc436384b93a
Autor:
Elodie Klajer, Marine Jary, Angélique Vienot, Aurélia Meurisse, Francine Fein, Clément Bolognini, Syrine Abdeljaoued, Hortense Chevalier, Dewi Vernerey, Meher Nasri, Anthony Turpin, Stefano Kim, Hamadi Almotlak, Thierry Nguyen, Christophe Borg, Elisabeta Gherga, Fabien Calcagno, Christelle d’Engremont
Publikováno v:
World Journal of Gastrointestinal Oncology. 12:332-346
FOLFOXIRI vs FOLFIRINOX as first-line chemotherapy in patients with advanced pancreatic cancer: A population-based cohort study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5bd22f47433905a42072504e54f296e5
https://doi.org/10.4251/wjgo.v12.i3.332
https://doi.org/10.4251/wjgo.v12.i3.332
Autor:
Meher Nasri, Amor Gamoudi, Syrine Abdeljaoued, Hamouda Boussen, Olfa Adouni, Lhem Bettaieb, H. Bouzaiene, Khaled Rahal, Aida Goucha
Publikováno v:
Breast Disease. 37:109-114
Background Male breast cancer (MBC) is a rare and neglected disease. Prognostic and predictive factors in MBC are extrapoled from trials conducted on its female counterpart. Objective Since the relationship between the transcription factor Forkhead b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40314e6726be6842e02b46ac794a4493
https://doi.org/10.3233/bd-170315
https://doi.org/10.3233/bd-170315
Publikováno v:
Cancer Biology & Medicine, Vol 14, Iss 2, Pp 187-190 (2017)
Cancer Biology & Medicine
Cancer Biology & Medicine
A new case of epithelioid hemangioendothelioma is reported to have occurred to a 67-year-old patient who consulted for right-sided chest pain. The work-up showed multiple right pulmonary lesions associated with bilateral moderate pleural effusion and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::331afe487a68cd506c13f9c27a0b88f2
http://www.cancerbiomed.org/index.php/cocr/article/view/1034
http://www.cancerbiomed.org/index.php/cocr/article/view/1034
Autor:
Khaled Rahal, Meher Nasri, Syrine Abdeljaoued, Hammouda Boussen, Olfa Adouni, Amor Gamoudi, Aida Goucha, Olfa El Amine, Ilhem Bettaieb
Publikováno v:
Oncology Research and Treatment. 40:167-172
Background: Several studies have outlined biological differences between female and male breast cancer (MBC) and concluded that MBC should be considered as an entirely separate disease. Whether FOXM1 has any indication for prognosis in MBC patients r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd5d2da399f9457bf8e62095ddab0a50
https://doi.org/10.1159/000458156
https://doi.org/10.1159/000458156
Autor:
Amel Mezlini, Henda Raies, Feryel Letaief, Yosra Yahyaoui, Mouna Ayadi, Amina Mokrani, Meher Nasri, Khedija Meddeb, Nesrine Chraiet
Publikováno v:
Cancer Biology & Medicine
Cancer Biology & Medicine, Vol 14, Iss 3, Pp 327-334 (2017)
Cancer Biology & Medicine, Vol 14, Iss 3, Pp 327-334 (2017)
Objective : To assess the response rate of patients with rectal adenocarcinoma to neoadjuvant therapy and to identify the predictors of histological regression after neoadjuvant radiotherapy (RT) or concurrent chemoradiotherapy (CCRT). Methods : This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b35906274974a346ff809e3458ecc2c2
http://europepmc.org/articles/PMC5570609
http://europepmc.org/articles/PMC5570609
Autor:
Angélique, Vienot, Hortense, Chevalier, Clément, Bolognini, Elisabeta, Gherga, Elodie, Klajer, Aurélia, Meurisse, Marine, Jary, Stefano, Kim, Christelle, d'Engremont, Thierry, Nguyen, Fabien, Calcagno, Hamadi, Almotlak, Francine, Fein, Meher, Nasri, Syrine, Abdeljaoued, Anthony, Turpin, Christophe, Borg, Dewi, Vernerey
Publikováno v:
World Journal of Gastrointestinal Oncology
BACKGROUND FOLFIRINOX regimen is the first-line reference chemotherapy (L1) in advanced pancreatic ductal adenocarcinoma (aPDAC). FOLFOXIRI, a schedule with a lower dose of irinotecan and no bolus 5-fluorouracil, has demonstrated efficacy and feasibi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::49486c447cc88a28bc34a4a5c8593e0b
https://pubmed.ncbi.nlm.nih.gov/32206183
https://pubmed.ncbi.nlm.nih.gov/32206183
